Treatment with cyclosporin A cream for the cutaneous reactions associated with imatinib therapy

Blood ◽  
2005 ◽  
Vol 105 (7) ◽  
pp. 2996-2997 ◽  
Author(s):  
Alejandro Schamun ◽  
Eduardo Bullorsky ◽  
German Stemmelin ◽  
Ricardo Saxton ◽  
Daniel Ricchione
Keyword(s):  
Cyclosporin A ◽  
Imatinib Therapy ◽  
Cutaneous Reactions

Cystic acne due to imatinib therapy for chronic myelocytic leukemia

2018 ◽  
Vol 25 (4) ◽  
pp. 972-974 ◽  
Author(s):  
Andrew Hwang ◽  
Andrew Iskandar ◽  
Michael del Rosario ◽  
Constantin A Dasanu
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Imatinib Mesylate ◽  
Side Effect ◽  
Medical Literature ◽  
Kinase Inhibitor ◽  
Imatinib Therapy ◽  
Chronic Myelocytic Leukemia ◽  
Myelocytic Leukemia ◽  
Cutaneous Reactions

Imatinib mesylate is a tyrosine kinase inhibitor used in the treatment of several malignancies. Its use, however, is associated with a number of toxic effects including adverse cutaneous reactions. Herein, we present a case of facial cystic acne in a patient receiving imatinib therapy for chronic myelocytic leukemia. This side effect resolved with cessation of therapy. To the best of our knowledge, this clinical entity has never been previously reported in the medical literature.

Managing cutaneous reactions to imatinib therapy

Blood ◽  
2002 ◽  
Vol 100 (9) ◽  
pp. 3434-3434 ◽  
Author(s):  
Simon A. J. Rule ◽  
Stephen G. O'Brien ◽  
Lucy C. Crossman
Keyword(s):  
Imatinib Therapy ◽  
Cutaneous Reactions

1869: Combined Therapy of FR167653 and Cyclosporin A Significantly Prolonged Animal Survival in ratRenal Allografts

2004 ◽  
Vol 171 (4S) ◽  
pp. 493-494
Author(s):  
Haruhito Azuma ◽  
Shiro Takahara ◽  
Takashi Wada ◽  
Takeshi Sakamoto ◽  
Akihiko Okuyama ◽  
...  
Keyword(s):  
Cyclosporin A ◽  
Combined Therapy ◽  
Animal Survival
Sign in / Sign up

Export Citation Format

Share Document